Igcon Beauty Cream is a topical formulation containing Hydroquinone 2% w/w, Mometasone 0.1% w/w, and Tretinoin 0.025% w/w, indicated for the treatment of hyperpigmentation disorders such as melasma, post-inflammatory hyperpigmentation, and other pigmentary abnormalities. Hydroquinone acts as a depigmenting agent by inhibiting the enzyme tyrosinase, thereby reducing melanin synthesis and promoting skin lightening. Mometasone, a potent corticosteroid, provides anti-inflammatory and immunosuppressive effects, helping to reduce erythema, swelling, and irritation associated with pigmentary conditions. Tretinoin, a retinoid derivative of vitamin A, facilitates increased epidermal turnover and promotes the dispersion of melanin granules, enhancing the efficacy of hydroquinone and improving skin texture. The combination of these active ingredients offers a synergistic approach to managing pigmentation disorders, improving skin tone uniformity and brightness. Igcon Beauty Cream should be applied once daily in the evening to the affected areas after cleansing, avoiding contact with eyes and mucous membranes. Use under medical supervision is recommended due to potential side effects such as skin irritation, dryness, or corticosteroid-induced skin thinning. Pregnant or lactating women should consult a healthcare professional prior to use.